Pharmaceuticals, Biotechnology and Life Sciences
Abivax kicked off book-building and the filing of an amended registration statement on Form F-1, to issue approximately 20,325,500 ordinary shares
Basilea Pharmaceutica has entered into an asset purchase agreement with privately owned Gravitas Therapeutics Inc. for GR-2397, a clinical-stage antifungal compound with a novel mechanism of action, targeting invasive mold infections caused by Aspergillus species.
Vetter Pharma has announced additional investments of €230 million in its new production building, which is currently under construction at the company’s global corporate headquarters site in Ravensburg, as it has recently reached a significant milestone in the construction process, as the shell of the building is now complete, following the start of construction in November 2021.
The first BIOTECH SUMMIT AUSTRIA – a milestone event for the Austrian and international biotechnology community – concluded on Friday in Graz, after two days of insightful discussions and networking.
BioNTech is evaluating the potential impact of Pfizer’s write-offs and other charges related to COMIRNATY on its financial results.
Positive results from a Phase 2b study (STREAM-AD) showed that amlitelimab significantly improved signs and symptoms of moderate-to-severe atopic dermatitis in adults whose disease cannot be adequately controlled with topical medications or for whom topical medications are not a recommended treatment approach.
CHMP has adopted a positive opinion in favor of approval of a Swiss specialty pharmaceutical company Santhera Pharmaceuticals’ AGAMREE (vamorolone) for the treatment of Duchenne Muscular Dystrophy patients aged 4 years and older.
Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and expansive lipid nanoparticle (LNP) patent…
Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the…
LANCASHIRE, England–(BUSINESS WIRE)–Victrex plc, a pioneer in the development of PEEK biomaterial solutions, have today launched a new product grade…